Skip to content

Continuous Glucose Monitoring (CGM) in Long Term Care (LTC) Facilities

Continuous Glucose Monitoring (CGM) to Assess Hypoglycemia in Older Adults With Diabetes in Long Term Care (LTC) Facilities

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05711108
Enrollment
86
Registered
2023-02-02
Start date
2022-01-19
Completion date
2024-12-31
Last updated
2025-10-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aging, Diabetes, Hypoglycemia

Keywords

older adults, hypoglycemia, continuous glucose monitoring, long-term care facilities

Brief summary

To prospectively determine the burden of hypoglycemia (minutes spent below 70 mg/dl per day, measured by continuous glucose monitor (CGM)) among residents of long term care facilities (LTC) with a diagnosis of type 1 or type 2 diabetes including key clinical subgroups (living in skilled nursing facility (SNF) or nursing home (NH), on different hypoglycemic medications). This aim will be achieved by recruiting 300 residents with diabetes in 4 LTC facilities. All participants will undergo masked CGM for 10 days.

Interventions

None listed

Sponsors

Theoria Medical
CollaboratorUNKNOWN
Joslin Diabetes Center
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults \>64 years with diagnosis of type 1 or type 2 diabetes * Using glucose-lowering medication or insulin

Exclusion criteria

* Currently taking or planning to take hydroxyurea * Patient or Health care proxy refuses to sign consent form

Design outcomes

Primary

MeasureTime frameDescription
Biochemical hypoglycemiaBaselineminutes per day sensor glucose \<70 mg/dL

Secondary

MeasureTime frameDescription
Time-in-rangeBaselinepercent/day over 10 days of glucose value between 90-180 mg/dl or 90-250 mg/dl depending current ADA recommendations)
Clinically significant hypoglycemiaBaselineminutes per day sensor glucose \<54 mg/dl
A1CBaseline
Falls, hospitalizationBaseline
Symptoms of hypoglycemia reported to the staff by the resident in between or at the time of fingerstick glucose monitoring (information derived from nursing notes)Baseline
Severe hypoglycemiaBaselineneeding 3rd party assistance

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026